
    
      Adult patients aged 21 or over with a diagnosis of alcohol-related liver disease and alcohol
      use disorder (AUD) and abstinent from alcohol for at least 2 weeks (but not more than 6
      months) prior to initiating acamprosate treatment.
    
  